Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

The aim of this open-label, multicenter, randomized phase II trial was to evaluate the efficacy and safety of zoledronic acid in combination with docetaxel in previously treated patients with non-small-cell lung cancer (NSCLC) and bone metastases. In this study, patients randomly received docetaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Haruyasu, Yamanaka, Takeharu, Seto, Takashi, Sugio, Kenji, Okamoto, Isamu, Sawa, Toshiyuki, Hirashima, Tomonori, Takeda, Koji, Atagi, Shinji, Fukuoka, Masahiro, Nakanishi, Yoichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317856/
https://www.ncbi.nlm.nih.gov/pubmed/24837137
http://dx.doi.org/10.1111/cas.12448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317856/
https://www.ncbi.nlm.nih.gov/pubmed/24837137
http://dx.doi.org/10.1111/cas.12448

Ejemplares similares